The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
Market view
opicapone · Powder
4 marketed package NDCs · 4 active manufacturers
Most dispensed: 50 mg · Capsule · #30 capsules/bottle · 25 mg · Capsule · #30 capsules/bottle
What changed in the last 90 days
Every detected change for opicapone, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
Same drug class
Other molecules FDA puts in Catechol-O-Methyltransferase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Opicapone in shortage right now?
- No. FDA does not currently list Opicapone in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Opicapone?
- 6 companies have marketed Opicapone in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Opicapone cost?
- The typical pharmacy pays about $24.76 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.